OKUR
Sign in
OnKure Therapeutics, Inc.
Save
106.03M
Market cap
104.75x
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors.
Similar securities
Based on sector and market capitalization
Report issue